Stroke Recovery and Rehabilitation Research: Issues, Opportunities, and the National Institutes of Health StrokeNet.

Stroke is the second leading cause of death and the third leading cause of disability-adjusted life years worldwide. Although numerous therapies have been developed over the past 10 years to treat acute ischemic stroke, the stark reality remains that only 5% of these patients are so treated in the United States,1 in part, because of treatment window times <3 to 6 hours post-onset, and many of these 5% nonetheless have significant long-term disability. Acute treatment options after hemorrhagic stroke remain limited.2 In parallel with efforts to further develop acute stroke interventions, researchers are studying recovery and rehabilitation treatments, which can have a treatment time window measured in days, weeks, or months poststroke. To achieve this goal, therapies aim to maximize function in brain areas that survive the stroke or provide compensatory approaches to improve overall function. Strategies targeting recovery and rehabilitation must be seen as distinct from acute stroke therapies, such as reperfusion or neuroprotection, where the strategy is to limit the severity of ischemic injury, including preserving penumbral tissue and reducing infarct size. Preclinical and translational research have successfully identified numerous molecular and physiological events spontaneously arising in the nervous system during the days-to-weeks after an infarct, and, subsequently, potential restorative therapies that target these events to improve long-term behavioral outcomes.3,4 In parallel, a burgeoning volume of data from human subjects has emerged regarding mechanisms of recovery from stroke. Together, these efforts inform translation into clinical studies for several classes of therapy, including small molecules, growth factors, stem cells, monoclonal antibodies, brain stimulation, robotics and other devices, cognitive strategies, intensive training, and telerehabilitation.5,6 The majority of patients with stroke survive the initial event but go on to live with significant disability for many years. Indeed, there are >7 million stroke survivors …

[1]  S. Savitz,et al.  Stem Cells as an Emerging Paradigm in Stroke 4: Advancing and Accelerating Preclinical Research. , 2019, Stroke.

[2]  S. Cramer,et al.  Moving Rehabilitation Research Forward: Developing Consensus Statements for Rehabilitation and Recovery Research* , 2017, Neurorehabilitation and neural repair.

[3]  Wenle Zhao,et al.  A surrogate-primary replacement algorithm for response-adaptive randomization in stroke clinical trials , 2017, Statistical methods in medical research.

[4]  Kendra M. Cherry-Allen,et al.  Dose response of task‐specific upper limb training in people at least 6 months poststroke: A phase II, single‐blind, randomized, controlled trial , 2016, Annals of neurology.

[5]  M. Maier,et al.  Upper Limb Outcome Measures Used in Stroke Rehabilitation Studies: A Systematic Literature Review , 2016, PloS one.

[6]  S. Carmichael Emergent properties of neural repair: elemental biology to therapeutic concepts , 2016, Annals of neurology.

[7]  Stanley P. Azen,et al.  Effect of a Task-Oriented Rehabilitation Program on Upper Extremity Recovery Following Motor Stroke: The ICARE Randomized Clinical Trial. , 2016, JAMA.

[8]  J. Broderick,et al.  The National Institutes of Health StrokeNet: A User's Guide. , 2016, Stroke.

[9]  Geoffrey A. Donnan,et al.  Recovery Potential After Acute Stroke , 2015, Front. Neurol..

[10]  Michael D Hill,et al.  Endovascular stent thrombectomy: the new standard of care for large vessel ischaemic stroke , 2015, The Lancet Neurology.

[11]  A. Leff,et al.  Using functional imaging to understand therapeutic effects in poststroke aphasia. , 2015, Current opinion in neurology.

[12]  A. Toga,et al.  Imaging in StrokeNet: Realizing the Potential of Big Data , 2015, Stroke.

[13]  Interrater Reliability of the Wolf Motor Function Test–Functional Ability Scale , 2015, Neurorehabilitation and neural repair.

[14]  Catherine E. Lang,et al.  Validity of Body-Worn Sensor Acceleration Metrics to Index Upper Extremity Function in Hemiparetic Stroke , 2015, Journal of neurologic physical therapy : JNPT.

[15]  E. Whyte,et al.  Overcoming practical challenges to conducting clinical research in the inpatient stroke rehabilitation setting , 2015, Topics in stroke rehabilitation.

[16]  Carl D. Hacker,et al.  Common Behavioral Clusters and Subcortical Anatomy in Stroke , 2015, Neuron.

[17]  Bimal Lakhani,et al.  Applications of Electroencephalography to Characterize Brain Activity: Perspectives in Stroke , 2015, Journal of neurologic physical therapy : JNPT.

[18]  Babak Shahbaba,et al.  Neural function, injury, and stroke subtype predict treatment gains after stroke , 2015, Annals of neurology.

[19]  P. Myles,et al.  Ethical and scientific considerations for patient enrollment into concurrent clinical trials , 2014, Trials.

[20]  Sook-Lei Liew,et al.  Non-invasive brain stimulation in neurorehabilitation: local and distant effects for motor recovery , 2014, Front. Hum. Neurosci..

[21]  Gottfried Schlaug,et al.  Predicting speech fluency and naming abilities in aphasic patients , 2013, Front. Hum. Neurosci..

[22]  R. Nudo,et al.  Management of patients with stroke: Is it time to expand treatment options? , 2013, Annals of neurology.

[23]  Cathy C. Y. Chou,et al.  A Standardized Approach to the Fugl-Meyer Assessment and Its Implications for Clinical Trials , 2013, Neurorehabilitation and neural repair.

[24]  S. Cramer,et al.  Biomarkers and Predictors of Restorative Therapy Effects After Stroke , 2013, Current Neurology and Neuroscience Reports.

[25]  R. Marshall,et al.  Stroke, Cognitive Deficits, and Rehabilitation: Still an Incomplete Picture , 2013, International journal of stroke : official journal of the International Stroke Society.

[26]  Maurizio Corbetta,et al.  Why use a connectivity-based approach to study stroke and recovery of function? , 2012, NeuroImage.

[27]  Matthew Petoe,et al.  The PREP algorithm predicts potential for upper limb recovery after stroke. , 2012, Brain : a journal of neurology.

[28]  J. Eng,et al.  Barriers to implementation of stroke rehabilitation evidence: findings from a multi-site pilot project , 2012, Disability and rehabilitation.

[29]  M. Chopp,et al.  Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation , 2012, The Lancet Neurology.

[30]  S. Warach,et al.  Standardizing the Structure of Stroke Clinical and Epidemiologic Research Data: The National Institute of Neurological Disorders and Stroke (NINDS) Stroke Common Data Element (CDE) Project , 2012, Stroke.

[31]  R. Teasell,et al.  Determining the need for in-patient rehabilitation services post-stroke: results from eight ontario hospitals. , 2012, Healthcare policy = Politiques de sante.

[32]  Steven C Cramer,et al.  Anatomy and physiology predict response to motor cortex stimulation after stroke , 2011, Neurology.

[33]  T. Jones,et al.  Experience-dependent neural plasticity in the adult damaged brain. , 2011, Journal of communication disorders.

[34]  OpeoluAdeoye,et al.  Recombinant Tissue-Type Plasminogen Activator Use for Ischemic Stroke in the United States , 2011 .

[35]  Dawn Kleindorfer,et al.  Recombinant Tissue-Type Plasminogen Activator Use for Ischemic Stroke in the United States: A Doubling of Treatment Rates Over the Course of 5 Years , 2011, Stroke.

[36]  Bruce H Dobkin,et al.  Body-weight-supported treadmill rehabilitation after stroke. , 2011, The New England journal of medicine.

[37]  T. Sanger,et al.  Harnessing neuroplasticity for clinical applications , 2011, Brain : a journal of neurology.

[38]  F. Chollet,et al.  Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial , 2011, The Lancet Neurology.

[39]  Alexander W Dromerick,et al.  Rehabilitation After Stroke: Current State of the Science , 2010, Current neurology and neuroscience reports.

[40]  B. Dobkin,et al.  Randomized, Placebo-Controlled, Double-Blind Study of Ropinirole in Chronic Stroke , 2009, Stroke.

[41]  A. Randolph The unique challenges of enrolling patients into multiple clinical trials , 2009, Critical care medicine.

[42]  Scott Barbay,et al.  The effects of amphetamine on recovery of function in animal models of cerebral injury: a critical appraisal. , 2009, NeuroRehabilitation.

[43]  Steven C Cramer,et al.  Repairing the human brain after stroke. II. Restorative therapies , 2008, Annals of neurology.

[44]  J. Kleim,et al.  Principles of experience-dependent neural plasticity: implications for rehabilitation after brain damage. , 2008, Journal of speech, language, and hearing research : JSLHR.

[45]  N. Yozbatiran,et al.  A Standardized Approach to Performing the Action Research Arm Test , 2008, Neurorehabilitation and neural repair.

[46]  S. Cramer,et al.  The case for modality-specific outcome measures in clinical trials of stroke recovery-promoting agents. , 2007, Stroke.

[47]  Susan Redmond,et al.  Lessons Learned in Participant Recruitment and Retention: The EXCITE Trial , 2006, Physical Therapy.

[48]  J. P. Miller,et al.  Effect of constraint-induced movement therapy on upper extremity function 3 to 9 months after stroke: the EXCITE randomized clinical trial. , 2006, JAMA.

[49]  Karl J. Friston,et al.  Non-invasive mapping of corticofugal fibres from multiple motor areas--relevance to stroke recovery. , 2006, Brain : a journal of neurology.

[50]  D. Corbett,et al.  Efficacy of Rehabilitative Experience Declines with Time after Focal Ischemic Brain Injury , 2004, The Journal of Neuroscience.

[51]  F. Müller,et al.  Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, double-blind study , 2001, The Lancet.

[52]  P. Sandercock,et al.  Framework for design and evaluation of complex interventions to improve health , 2000, BMJ : British Medical Journal.

[53]  P. Sandercock,et al.  Families of Trials: The Answers to All Our Questions? , 1999, Cerebrovascular Diseases.